Literature DB >> 8165195

Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approach.

N B Modi1, P Veng-Pedersen, D E Wurster, M J Berg, D D Schottelius.   

Abstract

The in vivo phenobarbital removal characteristics of three brands of activated charcoal (Actidose, Charcoaid, Superchar) were studied in normal volunteers using a system analysis approach. The subjects received a 200-mg dose of oral or intravenous phenobarbital followed by a single oral dose of 30 g of one of the three charcoals in a randomized crossover design. The relative merits of the three charcoals in enhancing the removal of oral and intravenous phenobarbital were assessed using a system analysis approach. The removal clearance, time to peak (tp), peak removal clearance (Rmax), percentage of dose removed (PCT infinity), and phenobarbital removal clearance (CLr) were calculated for the oral and intravenous treatments. Superchar had a pulse-like effect, with the shortest tp and the largest Rmax. Actidose and Charcoaid had similar effects, with Actidose inducing slightly greater phenobarbital removal. Superchar has the highest surface area and relative percentage of surface hydroxyl groups, whereas Actidose has the lowest surface area and relative percentage of surface hydroxyl groups of the three charcoals studied. Although correlations between the in vitro and the in vivo phenobarbital adsorption characteristics of the three charcoals may be difficult due to the presence of preservatives and palatibility enhancers in the commercial preparations, it appears that the in vivo effectiveness decreases as the surface area and the concentration of surface hydroxyl groups decrease. The proposed system analysis approach requires fewer assumptions than methods based on compartmental or physiologic approaches and has the advantage of describing the phenobarbital removal in a dynamic manner.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8165195     DOI: 10.1023/a:1018980029882

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

1.  Comparison of intestinal and peritoneal dialysis of theophylline and phenobarbitone in rats.

Authors:  K Arimori; Y Hashimoto; M Nakano
Journal:  J Pharm Pharmacol       Date:  1990-10       Impact factor: 3.765

2.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

3.  Surface characterization of activated charcoal by X-ray photoelectron spectroscopy (XPS): correlation with phenobarbital adsorption data.

Authors:  G M Burke; D E Wurster; M J Berg; P Veng-Pedersen; D D Schottelius
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

4.  Activated charcoal preparations--relative antidotal efficacy.

Authors:  A L Picchioni; L Chin; H E Laird
Journal:  Clin Toxicol       Date:  1974       Impact factor: 4.467

5.  Optimal antidotal dose of activated charcoal.

Authors:  L Chin; A L Picchioni; W M Bourn; H E Laird
Journal:  Toxicol Appl Pharmacol       Date:  1973-09       Impact factor: 4.219

6.  Comparative pharmacokinetics and pharmacodynamics of eterobarbital and phenobarbital in normal volunteers.

Authors:  N Barzaghi; G Gatti; R Manni; C A Galimberti; C Zucca; E Perucca; A Tartara
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jan-Mar       Impact factor: 2.441

7.  Linear systems approach to the analysis of an induced drug removal process. Phenobarbital removal by oral activated charcoal.

Authors:  W R Gillespie; P Veng-Pedersen; M J Berg; D D Schottelius
Journal:  J Pharmacokinet Biopharm       Date:  1986-02

8.  Acceleration of the body clearance of phenobarbital by oral activated charcoal.

Authors:  M J Berg; W G Berlinger; M J Goldberg; R Spector; G F Johnson
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

9.  Treatment of massive phenobarbital overdose with dopamine diuresis.

Authors:  J B Costello; A Poklis
Journal:  Arch Intern Med       Date:  1981-06

10.  Container residue after the administration of aqueous activated charcoal products.

Authors:  E P Krenzelok; R M Lush
Journal:  Am J Emerg Med       Date:  1991-03       Impact factor: 2.469

View more
  1 in total

1.  Comparative study of the adsorption of acetaminophen on activated carbons in simulated gastric fluid.

Authors:  Carlos A Rey-Mafull; Juan E Tacoronte; Raquel Garcia; Jorge Tobella; Julio C Llópiz; Alberto Iglesias; Dachamir Hotza
Journal:  Springerplus       Date:  2014-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.